Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,464Revenue $M2,105Net Margin (%)15.1Z-Score7.0
Enterprise Value $M9,879EPS $2.0Operating Margin %18.0F-Score7
P/E(ttm))27.4Cash Flow Per Share $0Pre-tax Margin (%)19.6Higher ROA y-yN
Price/Book5.610-y EBITDA Growth Rate %28.2Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %79.4Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %3.0ROA % (ttm)12.5Higher Current Ratio y-yY
Dividend Yield %0.5Insider Buy (3m)0ROE % (ttm)22.9Less Shares Outstanding y-yY
Payout Ratio %14.0Shares Outstanding M170ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
($42.03)
$ 55.5524%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
($43.29)
$ 55.5522%Add 56.30%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
($36.5)
$ 55.5534%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
($34.21)
$ 55.5538%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
($30.12)
$ 55.5546%New holding604,555
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RDY :

    Quarterly/Annual Reports about RDY:

      News about RDY:

      Articles On GuruFocus.com
      Emerging Market Stocks To Watch Out For Feb 17 2015 
      Should You Buy Actavis? Mar 18 2014 
      Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
      5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
      Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
      Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 


      More From Other Websites
      3 Large-Cap Pharmaceutical Companies to Invest in Right Now Apr 22 2015
      Curis Presents Preclinical Data on CUDC-427 at AACR Annual Meeting Apr 22 2015
      Curis Presents Preclinical Data on CUDC-427 at AACR Annual Meeting Apr 22 2015
      Curis Announces Presentation of Data from CUDC-427 and IRAK-4 Programs at AACR Annual Meeting Apr 16 2015
      Curis Announces Presentation of Data From CUDC-427 and IRAK-4 Programs at AACR Annual Meeting Apr 14 2015
      Dr Reddy's sees India sales growing 20 percent on new product launches Apr 10 2015
      Dr Reddy's sees India sales growing 20 percent on new product launches Apr 10 2015
      Dr. Reddy’s Laboratories and Its Subsidiary Promius PharmaTM Announce the Filing of Three NDAs... Apr 07 2015
      Dr. Reddy’s Laboratories and Its Subsidiary Promius PharmaTM Announce the Filing of Three NDAs... Apr 07 2015
      Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx... Apr 07 2015
      Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx... Apr 07 2015
      UCB to Sell Indian Established Brands Portfolio to Dr. Reddy's - Analyst Blog Apr 02 2015
      Sensex rises over 1 percent, posts first weekly gain in four Apr 01 2015
      Sensex rises over 1 percent, posts first weekly gain in four Apr 01 2015
      Dr. Reddy’s Laboratories to Acquire Select Portfolio of the Established Products Business of UCB... Apr 01 2015
      Dr. Reddy’s Laboratories to Acquire Select Portfolio of the Established Products Business of UCB... Apr 01 2015
      Dr Reddy's to buy some UCB brands for $128 million Apr 01 2015
      Dr Reddy's to buy some UCB brands for $128 million Apr 01 2015
      India Headlines: Sensex Crashes; Rupee Falls; Ford To Triple Exports Mar 26 2015
      India Headlines: GDP Growth of 7.8%, Foreign Investment Peaking? Mar 24 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK